Anorexia in Children

2

Review clinical trials related to Anorexia in Children. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Fecal Microbiota Transplant for Anorexia Nervosa

The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.

Participants needed: 20
Trial details
Age: 12-17Biological sex: FemaleType: InterventionalSponsor: Hamilton Health Sciences CorporationUpdated: May 27, 2026
Eligibility criteria

Be 12-17 years-old at time of recruitment [+4]

Exposure to antibiotics within two weeks of study randomization [+4]

Status: Recruiting

The Clinical Research of Auricular Magnet for Anorexia in Children

The aim of this randomized controlled cross-over trial is to explore the efficacy of auricular magnet in treating childhood anorexia. Participants will be allocated to two groups, labeled as Group A and Group B. Prior to the commencement of the trial, parents or guardians of the participants are required to fill out basic information for their children, including age, gender, height, weight, etc., and to complete the Preschooler's Eating Behavior Scale questionnaire. Over the initial 7-day period, participants of Group A receive auricular magnet therapy while participants of Group B undergo placebo magnetic auricular therapy. This is followed by a 14-day washout period to eliminate any lingering effects from the initial treatment. In the second phase, the treatments are swapped between the two groups.

Participants needed: 144
Trial details
Age: 2-6Biological sex: AllType: InterventionalSponsor: China Medical University HospitalUpdated: Oct 1, 2024Locations: 1
Eligibility criteria

Postprandial fullness [+4]